(S1 (S (S (NP (NP (JJ Regulatory) (NN T) (-LRB- -LRB-) (NN T) (NN reg) (-RRB- -RRB-) (NNS cells)) (VP (VBG expressing) (NP (NP (DT the) (NN transcription) (NN factor)) (NP (NP (NN forkhead) (NN box) (NN P3)) (PRN (-LRB- -LRB-) (NP (NN FOXP3)) (, ,) (NP (JJ human)) (: ;) (NP (NN Foxp3)) (, ,) (NP (NN mouse)) (-RRB- -RRB-)))))) (VP (VBP play) (NP (DT an) (JJ essential) (NN role)) (PP (IN in) (S (VP (VBG controlling) (NP (NP (JJ immune) (NNS responses)) (PP (TO to) (NP (NP (NNS autoantigens)) (, ,) (NP (NNS allergens)) (, ,) (NP (NN tumor) (NNS antigens)) (, ,) (NP (NN transplantation) (NNS antigens)) (, ,) (CC and) (NP (NP (JJ infectious) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNP Hori) (FW et) (FW al.) (, ,) (NP (NN 2003;Akdis)) (, ,) (NP (NN 2006))) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (S (NP (NN Foxp3)) (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (JJ forkhead/winged-helix) (NN family)) (PP (IN of) (NP (JJ transcriptional) (NNS regulators)))))))) (, ,) (CC and) (S (NP (NP (PRP$ its) (NN expression)) (PP (IN in) (NP (NN T) (NN reg) (NNS cells)))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (PRP$ their) (NN development)) (CC and) (NP (NN function))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fontenot) (FW et) (FW al.) (, ,) (NP (NNP 2003;Williams)) (CC and) (NP (NNP Rudensky))) (, ,) (NP (CD 2007))) (-RRB- -RRB-))))) (. .)))
(S1 (S (S (NP (NP (DT A) (JJ spontaneous) (NN mutation)) (PP (IN of) (NP (DT the) (NN X-linkedFoxp3gene) (NN inscurfymice)))) (VP (VBZ causes) (NP (DT an) (JJ autoimmune-like) (NN disease)))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN mutation)) (PP (IN in) (NP (NNS humans)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN immunodysregulation)) (, ,) (NP (NN polyendocrinopathy)) (, ,) (NP (NN enteropathy)) (, ,) (CC and) (NP (NP (JJ X-linked) (NN syndrome)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (JJ severe) (JJ multiorgan) (JJ autoimmune) (NN disease)) (SBAR (IN with) (S (NP (NP (NN hyper-IgE)) (PRN (-LRB- -LRB-) (NP (NP (NNP Ziegler)) (, ,) (NP (NN 2006))) (-RRB- -RRB-))) (VP (VBP .Although) (NP (NP (DT the) (JJ essential) (NN role)) (PP (IN of) (NP (NN Foxp3))) (PP (IN in) (NP (ADJP (ADJP (JJ central)) (CC and) (ADJP (JJ peripheral))) (NN tolerance)))) (VP (VBZ has) (VP (VBN been) (ADVP (RB extensively)) (VP (VBN studied) (UCP (, ,) (NP (PRP$ its) (NN regulation)) (, ,) (NP (NP (NN cooperation)) (PP (IN with) (NP (JJ other) (NN transcription) (NNS factors)))) (, ,) (CC and) (SBAR (WHADVP (WRB how)) (S (S (NP (PRP it)) (VP (VBZ functions) (PP (IN in) (NP (NP (NP (JJ inducible) (NN T) (CD reg)) (PRN (-LRB- -LRB-) (S (NP (PRP iT)) (NP (NN reg))) (-RRB- -RRB-))) (NNS cells))) (S (VP (TO to) (VP (VB suppress) (NP (JJ various) (NN target) (NNS genes))))))) (VP (VBZ is) (ADVP (RB mostly)) (RB not) (ADVP (RB yet)) (VP (VBN understood))))))))))))))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP (NN Foxp3)) (VP (VBZ cooperates) (PP (IN with) (NP (NP (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NFAT)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))))) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (JJ different) (NN target) (NNS genes)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Schubert) (FW et) (FW al.)) (, ,) (NP (NNP 2001;Bettelli) (FW et) (FW al.)) (, ,) (NP (NNP 2005;Wu) (FW et) (FW al.))) (, ,) (NP (NN 2006))) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN Th2) (NN cytokine) (NN IL-4)) (VP (VBZ inhibits) (NP (NN FOXP3) (NN expression)) (PP (IN during) (NP (NN T) (NN cell) (NN priming))))) (. .)))
(S1 (S (S (NP (NN GATA3)) (VP (VP (VBZ binds) (PP (TO to) (NP (NN theFOXP3promoter)))) (CC and) (VP (MD can) (VP (VB repress) (NP (DT the) (NN FOXP3) (NN trans-activation) (NN process)) (ADVP (RB directly)) (PP (IN in) (NP (NN Th2) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NP (NNP Mantel) (FW et) (FW al.)) (, ,) (NP (CD 2007))) (-RRB- -RRB-)))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (ADVP (RB further)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NP (CC both) (NP (NN Th1)) (CC and) (NP (NN Th2))) (NN transcription) (NNS factors)) (NP (NP (NN T-bet)) (CC and) (NP (NN GATA3)))) (VP (VBP oppose) (NP (NP (JJ peripheral) (NN induction)) (PP (IN of) (NP (NN Foxp3+T) (NN reg) (NNS cells))) (PP (IN in) (NP (NNS mice)))) (PP (IN through) (NP (NP (NN STAT1-)) (, ,) (NP (NN STAT4-)) (, ,) (CC and) (NP (NP (JJ STAT6-dependent) (NNS pathways)) (PRN (-LRB- -LRB-) (NP (NNP Wei) (FW et) (FW al.) (, ,) (CD 2007)) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (SBAR (IN Although) (S (NP (NP (JJ natural) (NN T) (NN reg) (-LRB- -LRB-) (NN nT) (NN reg) (-RRB- -RRB-) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP differentiate) (PP (IN in) (NP (DT the) (NN thymus))))))) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (PRP$ their) (JJ stable) (NN Foxp3) (NN expression))))))) (, ,) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (NP (PRP iT)) (NN reg) (NNS cells)) (ADJP (JJ specific) (PP (IN for) (NP (NP (NNS allergens)) (, ,) (NP (NNS alloantigens)) (, ,) (CC and) (NP (NNS autoantigens))))))) (PP (IN in) (NP (DT the) (NN periphery)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ transient) (NN Foxp3+phenotype)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fontenot) (FW et) (FW al.)) (, ,) (NP (NNP 2003;Hori) (FW et) (FW al.) (, ,) (CD 2003))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ crucial) (NN role)) (PP (IN of) (NP (NN TGF-beta))) (PP (IN in) (NP (PRP$ their) (NN generation)))) (VP (VBZ has) (VP (VBN been) (S (NP (NP (NN demonstrated.The) (NN RUNX) (NN gene) (NN family)) (PRN (-LRB- -LRB-) (NP (NP (JJ Runt-related) (NN transcription) (NN factor)) (, ,) (NP (NP (JJ acute) (JJ myeloid) (NN leukemia)) (PRN (-LRB- -LSB-) (NP (NN AML)) (-RRB- -RSB-))) (, ,) (NP (NP (JJ core-binding) (NN factor-alpha)) (PRN (-LRB- -LSB-) (NP (NN CBFalpha)) (-RRB- -RSB-))) (, ,) (CC and) (NP (NP (NN polyoma) (JJ enhancer-binding) (NN protein-2alpha)) (PRN (-LRB- -LSB-) (NP (NN PEBP2alpha)) (-RRB- -RSB-)))) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (CD three) (NNS members)) (, ,) (NP (NP (NP (NN RUNX1)) (PRN (-LRB- -LRB-) (NP (NN AML1/CBFA2/PEBP2alphaB)) (-RRB- -RRB-))) (, ,) (NP (NP (NN RUNX2)) (PRN (-LRB- -LRB-) (NP (CD AML3/CBFA1/) (NN PEBP2alphaA)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN RUNX3)) (PRN (-LRB- -LRB-) (NP (NN AML2/CBFA3/PEBP2alphaC)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (NP (PRP They)) (VP (VBP are) (NP (NP (JJ essential) (JJ transcriptional) (NNS regulators)) (PP (IN of) (NP (JJ different) (JJ developmental) (NNS pathways)))))) (. .)))
(S1 (S (S (NP (NN RUNX2)) (VP (VBZ is) (ADVP (RB mostly)) (ADJP (JJ important) (PP (IN for) (NP (NP (NN bone) (NN development)) (CC and) (NP (NN osteoblast) (NN differentiation))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Komori) (FW et) (FW al.)) (, ,) (NP (CD 1997))) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (S (NP (NN RUNX1)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN hematopoiesis))) (PP (IN during) (NP (NN development))))) (, ,) (CC and) (S (NP (NN RUNX3)) (VP (VBZ has) (NP (JJ important) (NNS functions)) (PP (IN in) (NP (NP (NN thymogenesis)) (CC and) (NP (NN neurogenesis)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Wang) (FW et) (FW al.)) (, ,) (NP (NNP 1996;Inoue) (FW et) (FW al.))) (, ,) (NP (NNP 2002;Levanon) (FW et) (FW al.) (, ,) (CD 2002) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (NP (NN RUNX1)) (CC and) (NP (NN RUNX3))) (ADVP (RB also)) (VP (VBP work) (ADVP (RB together)) (PP (IN in) (NP (NP (DT the) (NN establishment)) (PP (IN of) (NP (NP (NN lineage) (NN specification)) (PP (IN of) (NP (NP (NP (NN T) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NP (NNP Taniuchi) (FW et) (FW al.)) (, ,) (NP (NNP 2002;Egawa) (FW et) (FW al.) (, ,) (CD 2007))) (-RRB- -RRB-))) (NN .RUNX1is))))))))) (S (NP (NP (NP (DT a) (JJ frequent) (NN target)) (PP (IN for) (NP (NP (JJ chromosomal) (NNS translocations)) (VP (VBN associated) (PP (IN with) (NP (NNS leukemias))) (PRN (-LRB- -LRB-) (NP (NN Look)) (, ,) (NP (CD 1997)) (-RRB- -RRB-)))))) (, ,) (NP (NN andRUNX3methylation)) (CC and) (NP (NN silencing))) (VP (VBZ is) (VP (VBN observed) (PP (IN in) (NP (JJ various) (JJ human) (JJ epithelial) (NNS cancers))) (PRN (-LRB- -LRB-) (NP (NP (NNP Blyth) (FW et) (FW al.)) (, ,) (NP (CD 2005))) (-RRB- -RRB-))))) (S (NP (NN .RUNX) (NN family) (NNS members)) (VP (VBP share) (NP (NP (DT the) (NN Runt) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN DNA) (NN binding)) (PRN (-LRB- -LRB-) (NP (NP (NN Ito)) (, ,) (NP (CD 1999))) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN Runt) (JJ domain-containing) (NN protein)) (VP (VBZ constitutes) (NP (NP (DT the) (NN alpha-chain) (NN partner)) (PP (IN of) (NP (DT the) (JJ heterodimeric) (NN CBF) (NN complex)))))) (. .)))
(S1 (S (S (NP (NN RUNX) (NNS proteins)) (VP (VBP heterodimerize) (PP (IN with) (NP (NP (DT the) (JJ non-DNA-binding) (NN partner)) (, ,) (NP (NN CBFbeta)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ increases) (NP (NP (DT the) (NN affinity)) (PP (IN for) (NP (NN DNA) (NN binding))))) (CC and) (VP (VBZ stabilizes) (NP (DT the) (NN complex)) (PP (IN by) (S (VP (VBG preventing) (NP (JJ ubiquitin-dependent) (NN degradation))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Wang) (FW et) (FW al.)) (, ,) (NP (CD 1993))) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (DT The) (NN CBF) (NNS complexes)) (VP (VBP regulate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ cellular) (NNS genes)))) (PP (IN through) (S (VP (VBG binding) (PP (TO to) (NP (NP (NNS promoters)) (CC or) (NP (NN enhancer) (NNS elements))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT the) (NN RUNX-CBFbeta) (JJ complex) (NN regulation)))) (VP (VBP are) (ADVP (RB clearly)) (ADJP (NN cell) (NN lineage) (CC and) (NN stage) (JJ specific)))) (. .)))
(S1 (S (S (NP (PRP They)) (VP (VBP include) (NP (NP (DT the) (JJ crucial) (NNS choices)) (PP (IN between) (NP (NP (JJ cell-cycle) (NN exit)) (CC and) (NP (JJ continued) (NN proliferation)))) (PP (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN between) (NP (NP (NP (NP (NN cell) (NN differentiation)) (CC and) (NP (JJ self-renewal) (PRN (-LRB- -LRB-) (NP (NNP Blyth) (FW et) (FW al.) (, ,) (CD 2005)) (-RRB- -RRB-)) (NN .Because))) (PP (IN of) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN RUNX) (NNS mutations))) (PP (IN in) (NP (JJ different) (JJ autoimmune) (NNS diseases)))))) (CC and) (NP (NP (DT the) (JJ known) (NN interaction)) (PP (IN with) (NP (NN TGF-beta)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (NN RUNX1)) (CC and) (NP (NN RUNX3)))) (PP (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN FOXP3))))) (CC and) (ADVP (RB subsequently)) (PP (IN on) (NP (NP (NP (DT the) (NN development)) (CC and) (NP (NN function))) (PP (IN of) (NP (NP (PRP iT)) (NN reg) (NNS cells))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NP (NN RUNX1)) (CC and) (NP (NN RUNX3))) (VP (VBN induced) (PP (IN by) (NP (NN TGF-beta))))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NP (NN development)) (CC and) (NP (JJ suppressive) (NN function))) (PP (IN of) (NP (NN Foxp3+iT) (NN reg) (NNS cells))))))))))) (. .)))
